Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 23, 2001

View Archived Issues

Helinx technology successfully inactivates Trypanosoma cruzi

Antex concludes Phase I of SBIR grant from U.S. Army

Approval of Xeloda for treatment of breast cancer recommended in E.U.

R-105266 emerges from preclinical testing as safe and effective antiulcer agent

Clinical development update provided for CYC-202, a CDK2 inhibitor

Long-term tamsulosin has sustained efficacy, safety in LUTS/BPH

Novel products moving successfully through the pipeline at Millennium

Potentiation of insulin action by two different IR activators in insulin-resistant cells

Therapeutic efficacy demonstrated for selective ETA receptor antagonist in rat stroke model

Biogen highlights Q3 developments

Ariad presents a new small-molecule antitumor candidate targeting PTEN-deficient cancers

Vivus updates product pipeline

PARS inhibitors such as PJ-34 may be suitable for the therapy of septic shock

Cell Genesys commences phase II trial of GVAX vaccine for pancreatic cancer

Significant beneficial effects reported for PARP inhibitor in animal model of myocardial infarction

CPMP lifts Serdolect suspension; Lundbeck moves forward with postmarketing studies

Sangamo achieves first milestone in ZFP therapeutics program

Phase II trials of new treatment for atrial fibrillation set to begin

New agents for pain and inflammation designed at AstraZeneca

Cathepsin inhibitors from Ono particularly useful for inhibiting bone resorption

Hypoglycemic and hypolipidemic agents described by Takeda in recent patent

Synthesis and use of heterocyclic tyrosine kinase inhibitors for cancer, etc.

AstraZeneca patents new chemokine receptor modulators for psoriasis, COPD

MMP inhibitors and use in arthritis, atherosclerosis and COPD

Azign and the Center for Clinical and Basic Research to validate genes for obesity and diabetes

Curis receives third market approval for regeneration product

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...